The Allstate Corporation $ALL Shares Bought by Avanza Fonder AB

Avanza Fonder AB grew its holdings in The Allstate Corporation (NYSE:ALL) by 17.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,336 shares of the insurance provider’s stock after purchasing an additional 3,375 shares during the quarter. Avanza Fonder AB’s holdings in Allstate were worth $4,649,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. State Street Corp increased its holdings in shares of Allstate by 0.7% in the third quarter. State Street Corp now owns 11,859,517 shares of the insurance provider’s stock valued at $2,557,362,000 after purchasing an additional 85,468 shares during the last quarter. Boston Partners boosted its stake in Allstate by 14.9% during the third quarter. Boston Partners now owns 3,050,780 shares of the insurance provider’s stock worth $654,652,000 after buying an additional 395,195 shares during the last quarter. Raymond James Financial Inc. boosted its stake in Allstate by 3.3% during the second quarter. Raymond James Financial Inc. now owns 2,793,645 shares of the insurance provider’s stock worth $562,388,000 after buying an additional 88,620 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Allstate by 18.2% in the 3rd quarter. Dimensional Fund Advisors LP now owns 2,606,451 shares of the insurance provider’s stock valued at $559,435,000 after buying an additional 401,700 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Allstate in the 2nd quarter worth $482,870,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Allstate Trading Down 0.2%

NYSE ALL opened at $207.36 on Wednesday. The firm has a 50 day simple moving average of $204.42 and a 200-day simple moving average of $204.82. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.37 and a current ratio of 0.37. The Allstate Corporation has a one year low of $176.00 and a one year high of $216.75. The firm has a market cap of $53.82 billion, a price-to-earnings ratio of 5.43, a PEG ratio of 0.42 and a beta of 0.23.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, February 4th. The insurance provider reported $14.31 earnings per share for the quarter, topping the consensus estimate of $8.72 by $5.59. The firm had revenue of $17.35 billion for the quarter, compared to the consensus estimate of $17.23 billion. Allstate had a net margin of 15.19% and a return on equity of 39.20%. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the firm earned $7.67 EPS. Equities research analysts anticipate that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Allstate Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a dividend of $1.08 per share. This is an increase from Allstate’s previous quarterly dividend of $1.00. This represents a $4.32 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Monday, March 2nd. Allstate’s dividend payout ratio is currently 11.31%.

Insider Buying and Selling at Allstate

In other news, insider Suren Gupta sold 19,593 shares of the stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $210.00, for a total value of $4,114,530.00. Following the sale, the insider directly owned 100,646 shares in the company, valued at approximately $21,135,660. This trade represents a 16.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ALL has been the topic of several analyst reports. Morgan Stanley reiterated an “equal weight” rating and set a $215.00 price target (down from $245.00) on shares of Allstate in a report on Tuesday, December 16th. Roth Mkm raised their price objective on shares of Allstate from $230.00 to $240.00 and gave the stock a “buy” rating in a research report on Wednesday, November 26th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $220.00 target price on shares of Allstate in a research note on Thursday, February 5th. Evercore set a $225.00 target price on shares of Allstate in a report on Wednesday, January 7th. Finally, Mizuho dropped their price target on shares of Allstate from $281.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, March 20th. Four equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Allstate presently has an average rating of “Moderate Buy” and an average price target of $237.94.

Allstate Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.